Pennsaid

[Anonymous]

How's the training going for Pennsaid?

 

[Anonymous]

Who wants to know?

 

[Anonymous]

It's going swimmingly! The new pump action makes it way easier to dispense it up my rectum. Talk about relief for my monster hemorrhoids. Whew!

 

[Anonymous]

Seriously, as an investor in Nuvo Research, is Pennsaid 2% going to sell?

 

[Anonymous]

Seriously, as an investor in Nuvo Research, is Pennsaid 2% going to sell?

As an investor, you shouldn't even use this site for research on determining the success of a pipeline drug. This site is only good for discussions regarding the political discourse and pulse of overall salesforce morale.

With that said, Pennsaid 2% will have a better shot in the topical NSAID market that the original Pennsaid because it addresses the shortcomings of the first product. And the original Pennsaid worked wonders for patients when dosed and applied correctly. Since 2% is an improvement in key areas, the product should do well out of the starting gates. I'm just speaking anecdotally from the standpoint of my territory.

 

[Anonymous]

I heard from multiple sources that this new pennsaid 2% should be a much easier sell to the public when compared to Pennsaid 1.5% or the competition for that matter because it is very user friendly and easy to use because it is much, much cleaner to use! A little promo will go a long way! I have to say it sounds pretty good!

 

[Anonymous]

When was the last time a pharmaceutical company improved a drug and lowered the price?
This is a winner...2%-2 metered pumps-2X daily
For just a $10 co-pay!

 

[Anonymous]

I heard from multiple sources that this new pennsaid 2% should be a much easier sell to the public when compared to Pennsaid 1.5% or the competition for that matter because it is very user friendly and easy to use because it is much, much cleaner to use! A little promo will go a long way! I have to say it sounds pretty good!

What the hell are you talking about? The product is barely on pharmacy shelves and we don't even have the demo bottles yet. Are your sources the clinical investigators or the patients from the trials? Think before you type.

 

[Anonymous]

Seriously, as an investor in Nuvo Research, is Pennsaid 2% going to sell?

IF you are an investor ,what the heck are you doing on cafe pharma? You are a moron and what kind of valuable information are you going to learn?/

 

[Anonymous]

How does this compare to the topical compound creams. Is this better?

 

[Anonymous]

How does this compare to the topical compound creams. Is this better?

All I know is i think I might quit and sell for one of these compound pharmacies. I've heard of reps making 30K a month, I think it's a little late to the party though.

 

[Anonymous]

Compounded Creams cost patients a lot more than $10 per Rx. These pharmacies pay great money for a year or two to build the business and forge relationships with HCPs.

They then get rid of the rep and ride the wave of business that is on autopilot.

The starting base salary and initial bonuses are great but the remaining bennies are light.